Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma

Molecular Systems Biology

Volumn 8, Issue , 2012, Pages

  Wiśniewski, Jacek R ^a   Ostasiewicz, Paweł ^a,b   Duś, Kamila ^a,b   Zielińska, Dorota F ^a   Gnad, Florian ^a,c   Mann, Matthias ^a,d  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c GENENTECH INC   (United States)

^d University of Copenhagen   (Denmark)

Author keywords

colon cancer; FASP; FFPE tissue; microdissection; quantitative proteomics

Indexed keywords

PROTEOME; PARAFFIN; TRANSCRIPTOME; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CANCER TISSUE; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN CACO 2; CELL SURFACE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; FEMALE; FUNCTIONAL PROTEOMICS; GENE DOSAGE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MICRODISSECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR CELL; ADENOCARCINOMA; CELL FRACTIONATION; COLON; COLON TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LASER CAPTURE MICRODISSECTION; METABOLISM; METASTASIS; PATHOLOGY; PROTEOMICS; SIGNAL TRANSDUCTION; TISSUE FIXATION; UPREGULATION;

ADENOCARCINOMA; CACO-2 CELLS; CELL DIFFERENTIATION; COLON; COLONIC NEOPLASMS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LASER CAPTURE MICRODISSECTION; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TISSUE FIXATION; TRANSCRIPTOME; UP-REGULATION;

EID: 84872685287     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2012.44     Document Type: Article

References (63)

1. Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR (2010) Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics 9: 988-1005
2. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R (2011) The quantitative proteome of a human cell line. Mol Syst Biol 7: 549
3. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful aproach to multiple testing. J R Stat Soc 57: 289-300
4. Besson D, Pavageau AH, Valo I, Bourreau A, Belanger A, Eymerit-Morin C, Mouliere A, Chassevent A, Boisdron-Celle M, Morel A, Solassol J, Campone M, Gamelin E, Barré B, Coqueret O, Guette C (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 10: M111.009712
5. Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, Laurberg S, Sorensen FB, Hagemann R, ØRntoft TF (2002) Gene expression in colorectal cancer. Cancer Res 62: 4352-4363 (Pubitemid 34827293)
6. Buhrke T, Lengler I, Lampen A (2011) Analysis of proteomic changes induced upon cellular differentiation of the human intestinal cell line Caco-2. Dev Growth Differ 53: 411-426
7. Buschmann RJ, Manke DJ (1981) Morphometric analysis of the membranes and organelles of small intestinal enterocytes. I. Fasted Hamster. J Ultrastruct Res 76: 1-14
8. Cardoso J, Boer J, Morreau H, Fodde R (2007) Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 1775: 103-137 (Pubitemid 44881195)
9. Conrotto P, Roesli C, Rybak J, Kischel P, Waltregny D, Neri D, Castronovo V (2008) Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer 123: 2856-2864
10. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372
11. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794-1805
12. Crowe PT, Marsh MN (1993) Morphometric analysis of small intestinal mucosa. IV. Determining cell volumes. Virchows Arch A Pathol Anat Histopathol 422: 459-466 (Pubitemid 23223661)
13. de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Ponten F, Meijer GA, Fijneman RJ (2012) Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut 61: 855-864
14. Ellis RJ (2001) Macromolecular crowding: obvious but underappreciated. Trends Biochem Sci 26: 597-604 (Pubitemid 32925190)
15. Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6: 479-507
16. Gamez-Pozo A, Sanchez-Navarro I, Calvo E, Agullo-Ortuno MT, Lopez-Vacas R, Diaz E, Camafeita E, Nistal M, Madero R, Espinosa E, López JA, Fresno Vara JÁ (2012) PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics. PLoS ONE 7: e33752
17. Garty H, Karlish SJ (2006) Role of FXYD proteins in ion transport. Annu Rev Physiol 68: 431-459
18. Geiger T, Cox J, Ostasiewicz P, Wisniewski JR, Mann M (2010) Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 7: 383-385
19. Han CL, Chen JS, Chan EC, Wu CP, Yu KH, Chen KT, Tsou CC, Tsai CF, Chien CW, Kuo YB, Lin PY, Yu JS, Hsueh C, Chen MC, Chan CC, Chang YS, Chen YJ (2011) An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol Cell Proteomics 10: M110.003087
20. Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452: 571-579 (Pubitemid 351483371)
21. Harrell JC, Prat A, Parker JS, Fan C, He X, Carey L, Anders C, Ewend M, Perou CM (2011) Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat 132: 523-535
22. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945
23. Jimenez CR, Knol JC, Meijer GA, Fijneman RJ (2010) Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics 73: 1873-1895
24. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY(2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121: 2005-2012
25. Kimura H, Tao Y, Roeder RG, Cook PR (1999) Quantitation of RNA polymerase II and its transcription factors in an HeLa cell: little soluble holoenzyme but significant amounts of polymerases attached to the nuclear substructure. Mol Cell Biol 19: 5383-5392 (Pubitemid 29339897)
26. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, Nesland JM, Myklebost O, Rognum TO, Giercksky KE, Skotheim RI, Lothe RA (2007) Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 6: 2
27. Koehler A, Bataille F, Schmid C, Ruemmele P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W (2004) Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 204: 65-74 (Pubitemid 39214483)
28. Kok LF, Lee MY, Tyan YS, Wu TS, Cheng YW, Kung MF, Wang PH, Han CP (2010) Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study. Arch Gynecol Obstet 281: 293-300
29. Kwong KY, Bloom GC, Yang I, Boulware D, Coppola D, Haseman J, Chen E, McGrath A, Makusky AJ, Taylor J, Steiner S, Zhou J, Yeatman TJ, Quackenbush J(2005) Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 86: 142-158 (Pubitemid 40917221)
30. Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR (2011) Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS ONE 6: e16636
31. Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, McCall JL, Reeve AE (2007) Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 17: 1541-1549
32. Lodish H, Berk A, Zipursky S, Matsudaira P, Baltimore D, Darnell J (eds) (2000) Molecular Cell Biology. 4th edn, New York: W.H. Freeman
33. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, Akira S, Wiegand M, Hochrein H, O'Keeffe M, Mann M (2010) Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32: 279-289
34. MacLeod RJ, Hamilton JR, Bateman A, Belcourt D, Hu J, Bennett HP, Solomon S (1991) Corticostatic peptides cause nifedipine-sensitive volume reduction in jejunal villus enterocytes. Proc Natl Acad Sci USA 88: 552-556 (Pubitemid 21915503)
35. Meding S, Balluff B, Elsner M, Schone C, Rauser S, Nitsche U, Maak M, Schafer A, Hauck SM, Ueffing M, Langer R, Höfler H, Friess H, Rosenberg R, Walch A (2012) Tissue based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J Pathol (advance online publication, 19 March 2012; doi:10.1002/path.4021)
36. Michalski A, Damoc E, Hauschild JP, Lange O, Wieghaus A, Makarov A, Nagaraj N, Cox J, Mann M, Horning S(2011) Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics 10: M111.011015
37. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Paabo S, Mann M (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 7: 548
38. Nambiar PR, Gupta RR, Misra V (2010) An 'Omics' based survey of human colon cancer. Mutat Res 693: 3-18
39. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G (2009) Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 35: 201-209
40. Notterman DA, Alon U, Sierk AJ, Levine AJ (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130 (Pubitemid 32691964)
41. Olsen JV, Macek B, Lange O, Makarov A, Horning S, Mann M (2007) Higher-energy C-trap dissociation for peptide modification analysis. Nat Methods 4: 709-712 (Pubitemid 47338163)
42. Olsen JV, Schwartz JC, Griep-Raming J, Nielsen ML, Damoc E, Denisov E, Lange O, Remes P, Taylor D, Splendore M, Wouters ER, Senko M, Makarov A, Mann M, Horning S (2009) A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol Cell Proteomics 8: 2759-2769
43. Ostasiewicz P, Zielinska DF, Mann M, Wisniewski JR (2010) Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res 9: 3688-3700
44. Pan S, Chen R, Brand RE, Hawley S, Tamura Y, Gafken PR, Milless BP, Goodlett DR, Rush J, Brentnall TA (2012) Multiplex targeted proteomic assay for biomarker detection in plasma: A pancreatic cancer biomarker case study. J Proteome Res 11: 1937-1948
45. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, Buttgereit F, Bennink JR, Yewdell JW (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354 (Pubitemid 36351514)
46. Schaefer O, Ohtsuki S, Kawakami H, Inoue T, Liehner S, Saito A, Sakamoto A, Ishiguro N, Matsumaru T, Terasaki T, Ebner T (2012) Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucurono-syltransferases in cultured primary human hepatocytes. Drug Metab Dispos 40: 93-103
47. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M (2011) Global quantification of mammalian gene expression control. Nature 473: 337-342
48. Shi H, Hood KA, Hayes MT, Stubbs RS (2011) Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis. J Proteomics 75: 339-351
49. van Holde KE (1989) Chromatin. New York: Springer Verlag
50. Van Houdt W, Emmink B, Pham T, Piersma S, Verheem A, Vries R, Fratantoni S, Pronk A, Clevers H, Borel Rinkes I, Jimenez CR, Kranenburg O (2011) Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies birc6 as a potential therapeutic target. Mol Cell Proteomics 10: M111.011353
51. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033
52. Warburg O (1956) On respiratory impairment in cancer cells. Science 124: 269-270
53. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100: 15901-15905 (Pubitemid 38021087)
54. Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, Dai H, Peterse JL, van't Veer LJ (2005) No common denominator for breast cancer lymph node metastasis. Br J Cancer 93: 924-932 (Pubitemid 41487019)
55. Wisniewski JR (2011) Tools for phospho-and glycoproteomics of plasma membranes. Amino Acids 41: 223-233
56. Wisniewski JR, Mann M (2012) Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis. Anal Chem 84: 2631-2637
57. Wisniewski JR, Ostasiewicz P, Mann M (2011a) High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J Proteome Res 10: 3040-3049
58. Wisniewski JR, Zielinska DF, Mann M (2011b) Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by the filter-aided sample preparation method. Anal Biochem 410: 307-309
59. Wisniewski JR, Zougman A, Mann M (2009a) Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res 8: 5674-5678
60. Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009b) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362
61. Yanagawa R, Furukawa Y, Tsunoda T, Kitahara O, Kameyama M, Murata K, Ishikawa O, Nakamura Y (2001) Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 3: 395-401 (Pubitemid 32988809)
62. Zeiler M, Straube WL, Lundberg E, Uhlen M, Mann M (2012) A Protein Epitope Signature Tag (PrEST) library allows SILAC-based absolute quantification and multiplexed determination of protein copy numbers in cell lines. Mol Cell Proteomics 11: O111.009613
63. Zweibaum A, Triadou N, Kedinger M, Augeron C, Robine-Leon S, Pinto M, Rousset M, Haffen K (1983) Sucrase-isomaltase: A marker of foetal and malignant epithelial cells of the human colon. Int J Cancer 32: 407-412 (Pubitemid 13017953)